Life Sciences Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program AIT News Desk Jun 27, 2022 Vir Biotechnology, Inc. announced new data from its robust hepatitis B virus (HBV) clinical trial program, including results from an ongoing Phase 2…